APEALEA Trademark

Trademark Overview

On Wednesday, February 6, 2019, a trademark application was filed for APEALEA with the United States Patent and Trademark Office. The USPTO has given the APEALEA trademark a serial number of 79253947. The federal status of this trademark filing is REGISTERED as of Tuesday, December 31, 2019. This trademark is owned by Oasmia Pharmaceutical AB (publ). The APEALEA trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for human purposes for the treatment of cancer; human cancer medicines, namely, pharmaceutical products for the prevention and treatment of cancer
apealea

General Information

Serial Number79253947
Word MarkAPEALEA
Filing DateWednesday, February 6, 2019
Status700 - REGISTERED
Status DateTuesday, December 31, 2019
Registration Number5946884
Registration DateTuesday, December 31, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 15, 2019

Trademark Statements

Goods and ServicesMedicines for human purposes for the treatment of cancer; human cancer medicines, namely, pharmaceutical products for the prevention and treatment of cancer
Translation of Words in MarkThe wording "APEALEA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOasmia Pharmaceutical AB (publ)
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSE
Party NameOasmia Pharmaceutical AB (publ)
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSE
Party NameOasmia Pharmaceutical AB (publ)
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSE

Trademark Events

Event DateEvent Description
Monday, May 17, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 17, 2020INTERNATIONAL REGISTRATION RENEWED
Friday, May 15, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 8, 2020NOTIFICATION PROCESSED BY IB
Thursday, April 16, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 16, 2020FINAL DISPOSITION PROCESSED
Tuesday, March 31, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 31, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, October 15, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 15, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 25, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 25, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 7, 2019ASSIGNED TO LIE
Tuesday, September 3, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 14, 2019REFUSAL PROCESSED BY IB
Wednesday, May 15, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 14, 2019REFUSAL PROCESSED BY MPU
Friday, April 19, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 18, 2019NON-FINAL ACTION WRITTEN
Wednesday, April 17, 2019ASSIGNED TO EXAMINER
Saturday, March 23, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, March 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 7, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

apealea cancer human treatment medicines prevention products pharmaceutical namely purposes